FLT3 and acute myeloid leukemia: Maintenance Decitabine (DAC) Improves Disease‐Free (DFS) and Overall Survival (OS) after Intensive Therapy for Acute Myeloid Leukemia (AML) in Older Adults, Particularly in FLT3‐ITD‐Negative Patients: ECOG‐ACRIN (E‐A) E2906 Randomized Study